Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders
1 x
$
30.00
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
1 x
$
30.00
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
1 x
$
30.00
Pharmacological Interventions versus Combined Treatment of Depression: A Prospective Study
1 x
$
30.00
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
1 x
$
30.00
Captagone & Morbid Jealousy
1 x
$
30.00
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)
1 x
$
30.00
MDMA to Treat PTSD in Adults
1 x
$
30.00
View Cart
Checkout
Home
Cart
Cart
MedWorks
2015-01-23T07:24:01-08:00
You Have 8 Items In Your Cart
Product
Price
Quantity
Subtotal
Remove
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders
$
30.00
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders quantity
$
30.00
×
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
$
30.00
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies quantity
$
30.00
×
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
$
30.00
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis quantity
$
30.00
×
Pharmacological Interventions versus Combined Treatment of Depression: A Prospective Study
$
30.00
Pharmacological Interventions versus Combined Treatment of Depression: A Prospective Study quantity
$
30.00
×
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
$
30.00
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients quantity
$
30.00
×
Captagone & Morbid Jealousy
$
30.00
Captagone & Morbid Jealousy quantity
$
30.00
×
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)
$
30.00
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD) quantity
$
30.00
×
MDMA to Treat PTSD in Adults
$
30.00
MDMA to Treat PTSD in Adults quantity
$
30.00
×
Update cart
Cart totals
Subtotal
$
240.00
Total
$
240.00
Update cart
Proceed to checkout
Close product quick view
×
Title
Page load link
Go to Top